本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Akoya Biosciences, Inc.

0.9935
+0.04785.05%
成交量:6.80万
成交额:6.60万
市值:4,955.12万
市盈率:-1.04
高:0.9999
开:0.9310
低:0.9310
收:0.9457
数据加载中...
2025/05/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/13

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/05/13

重要事件披露

Form 8-K - Current report
2025/05/12

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/04/29

重要事件披露

Form 8-K - Current report
2025/04/29

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/04/29

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/04/28

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2025/04/04

重要事件披露

Form 8-K - Current report
2025/04/04

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/04/04

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/03/18

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/03/17

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/03/17

重要事件披露

Form 8-K - Current report
2025/03/17

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/17

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/04

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/02/25

企业合并公告

Form 425 - Prospectuses and communications, business combinations
2025/02/25

重要事件披露

Form 8-K - Current report
2025/02/25

企业合并公告

Form 425 - Prospectuses and communications, business combinations